ciclopirox has been researched along with Candidiasis, Vulvovaginal in 13 studies
Candidiasis, Vulvovaginal: Infection of the VULVA and VAGINA with a fungus of the genus CANDIDA.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Thirty-four patients at the end of pregnancy were treated with ciclopiroxolamine (Dafnegin) vaginally for the period from January to October 1998." | 5.09 | [The treatment of acute mycotic colpitis with ciclopiroxolamine (Dafnegin-CSC) in pregnant patients in the 10th lunar month]. ( Damianov, L; Ivanov, S; Novachkov, V; Tsankova, M, 1999) |
| "Micafungin is a new echinocandin drug with a wide antifungal spectrum including rare Candida species." | 2.77 | [Candida glabrata : pathogenicity and therapy update]. ( Tietz, HJ, 2012) |
| "They presented signs and symptoms of genital candidiasis and had positive smear culture for Candida." | 2.69 | [Effectiveness and safety of ciclopirox olamine 1% vaginal cream versus terconazole 0.8% vaginal cream in the treatment of genital candidiasis]. ( Cruz Talonia, F; García Figueroa, RG; Ramírez Palacios, D; Romero Cabello, R; Sauceda, L, 2000) |
| "Ciclopirox olamine is a substituted pyridone antimycotic, unrelated to the imidazole derivatives, with activity against a broad spectrum of dermatophytes, yeasts, actinomycetes, molds, other fungi, and a variety of Gram-positive and Gram-negative bacteria." | 2.37 | Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use. ( Brogden, RN; Dawson, GW; Jue, SG, 1985) |
| "Mostly, recurrences are caused by identical Candida strains suggesting C." | 1.37 | Recurrent vulvovaginal candidosis: focus on the vulva. ( Beikert, FC; Clad, A; Koeninger, A; Le, MT; Technau, K, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (46.15) | 18.7374 |
| 1990's | 3 (23.08) | 18.2507 |
| 2000's | 1 (7.69) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 1 (7.69) | 2.80 |
| Authors | Studies |
|---|---|
| Farr, A | 1 |
| Effendy, I | 1 |
| Frey Tirri, B | 1 |
| Hof, H | 1 |
| Mayser, P | 1 |
| Petricevic, L | 1 |
| Ruhnke, M | 1 |
| Schaller, M | 1 |
| Schaefer, APA | 1 |
| Sustr, V | 1 |
| Willinger, B | 1 |
| Mendling, W | 1 |
| Beikert, FC | 1 |
| Le, MT | 1 |
| Koeninger, A | 1 |
| Technau, K | 1 |
| Clad, A | 1 |
| Tietz, HJ | 1 |
| Peil, HG | 1 |
| Wajnberg, M | 1 |
| Wajnberg, A | 1 |
| Grozdanov, G | 1 |
| Krumov, G | 1 |
| Milchev, N | 1 |
| Damianov, L | 2 |
| Novachkov, V | 2 |
| Ivanov, S | 2 |
| Tsankova, M | 1 |
| García Figueroa, RG | 1 |
| Sauceda, L | 1 |
| Ramírez Palacios, D | 1 |
| Cruz Talonia, F | 1 |
| Romero Cabello, R | 1 |
| Bucciero, A | 1 |
| Molteni, E | 1 |
| Molteni, B | 1 |
| Mariani, W | 1 |
| Jacobellis, M | 1 |
| Jasonni, VM | 1 |
| La Marca, L | 1 |
| Naldi, S | 1 |
| De Paoli, L | 1 |
| Flamigni, C | 1 |
| Jue, SG | 1 |
| Dawson, GW | 1 |
| Brogden, RN | 1 |
| Rustichelli, S | 1 |
| Coppola, C | 1 |
| Tumiati, L | 1 |
| Giacardi, M | 1 |
| Carbone, G | 1 |
| Cosentina, R | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Ketoconazole In Situ Gel Versus Terconazole Cream for Treatment of Vaginal Candidiasis[NCT03473418] | Phase 3 | 69 participants (Anticipated) | Interventional | 2018-04-01 | Not yet recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for ciclopirox and Candidiasis, Vulvovaginal
| Article | Year |
|---|---|
Guideline: Vulvovaginal candidosis (AWMF 015/072, level S2k).
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis, Vulvovagi | 2021 |
Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use.
Topics: Animals; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Vulvovaginal; Ciclopirox; Dermatomy | 1985 |
5 trials available for ciclopirox and Candidiasis, Vulvovaginal
| Article | Year |
|---|---|
[Candida glabrata : pathogenicity and therapy update].
Topics: Administration, Topical; Antifungal Agents; Candida glabrata; Candidiasis, Cutaneous; Candidiasis, V | 2012 |
[Open clinical study on the efficacy and tolerance of ciclopiroxolamine in vulvovaginal candidosis (author's transl)].
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis, Vulvovaginal; Ciclopirox; Clinical Trials a | 1981 |
[A comparative double blind trial with vaginal creams of cyclopyroxolamine and miconazole in vulvovaginal candidosis (author's transl)].
Topics: Adult; Candidiasis, Vulvovaginal; Ciclopirox; Double-Blind Method; Female; Humans; Imidazoles; Micon | 1981 |
[The treatment of acute mycotic colpitis with ciclopiroxolamine (Dafnegin-CSC) in pregnant patients in the 10th lunar month].
Topics: Acute Disease; Antifungal Agents; Candidiasis, Vulvovaginal; Ciclopirox; Female; Humans; Pregnancy; | 1999 |
[Effectiveness and safety of ciclopirox olamine 1% vaginal cream versus terconazole 0.8% vaginal cream in the treatment of genital candidiasis].
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Ciclopirox; Female; Humans; Pyridon | 2000 |
6 other studies available for ciclopirox and Candidiasis, Vulvovaginal
| Article | Year |
|---|---|
Recurrent vulvovaginal candidosis: focus on the vulva.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Biopsy; Candida albicans; Candidia | 2011 |
[The treatment of mycotic colpitis with the preparation Batrafen].
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Ciclopirox; Drug Evaluation; Female | 1993 |
[The treatment of acute mycotic colpitis with ciclopiroxolamine in patients using oral contraceptives].
Topics: Acute Disease; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Ciclopirox; Contrace | 1997 |
[Ciclopiroxolamine in the topical treatment of vaginal mycoses].
Topics: Administration, Topical; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Ciclopirox; Drug Evalu | 1989 |
[Controlled clinical study of cyclopyroxolamine in vaginal candidiasis].
Topics: Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Ciclopirox; Drug Evaluation; Female; Humans; Mi | 1989 |
[Cyclopyroxalamine: preliminary considerations on the use of a new non-imidazole antifungal agent in infectious genital pathology].
Topics: Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Ciclopirox; Female; Humans; Middle | 1987 |